Barbara D. Lipes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Barbara D. Lipes has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Daniel J. Kenan
Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710, United States
3 shared publications- Michael Dee Gunn
Duke University Medical Center
3 shared publications - Herman F. Staats
Department of Pathology, Duke University Medical Center, Durham, NC, USA
2 shared publications Yu-Hsun Chen
Department of Immunology, Duke University Medical Center, Durham, North Carolina 27710, United States
2 shared publications- Aiwei Yan
Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn
1 shared publication Angus Hucknall
Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA
1 shared publication
Latest Publications
- Open Access
- 20 June 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (12) , e029390
Differential Response of Engineered Human Cardiac Tissues to Delta and Omicron COVID‐19 Virus
- 20 June 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (12) , e029390
Open AccessDifferential Response of Engineered Human Cardiac Tissues to Delta and Omicron COVID‐19 Virus
- 7 April 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (588)
Ultrasensitive point-of-care immunoassay for secreted glycoprotein detects Ebola infection earlier than PCR
An immunoassay that targets the nonstructural secreted glycoprotein decoy antigen of Ebola virus detects infection earlier than PCR.
- 7 April 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (588)
Ultrasensitive point-of-care immunoassay for secreted glycoprotein detects Ebola infection earlier than PCR
An immunoassay that targets the nonstructural secreted glycoprotein decoy antigen of Ebola virus detects infection earlier than PCR.
- Open Access
- 30 January 2009
- Published by Elsevier in Journal of Immunological Methods
- Vol. 340 (2) , 144-153
Identification of recombinant antibodies against multiple distinct toll-like receptors by homolog mining a single immune scFv phage library
- 30 January 2009
- Published by Elsevier in Journal of Immunological Methods
- Vol. 340 (2) , 144-153
Open AccessIdentification of recombinant antibodies against multiple distinct toll-like receptors by homolog mining a single immune scFv phage library
- Open Access
- 1 May 2008
- Published by Elsevier in Journal of Molecular Biology
- Vol. 379 (2) , 261-272
An Entirely Cell-Based System to Generate Single-Chain Antibodies against Cell Surface Receptors
- 1 May 2008
- Published by Elsevier in Journal of Molecular Biology
- Vol. 379 (2) , 261-272
Open AccessAn Entirely Cell-Based System to Generate Single-Chain Antibodies against Cell Surface Receptors
- 15 May 2007
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 67 (10) , 4716-4724
Angiostatin-Like Activity of a Monoclonal Antibody to the Catalytic Subunit of F1F0 ATP Synthase
The antiangiogenic protein angiostatin inhibits ATP synthase on the endothelial cell surface, blocking cellular proliferation. To examine the specificity of this interaction, we generated monoclonal antibodies (mAb) directed against ATP synthase. mAb directed against the β-catalytic subunit of ATP synthase (MAb3D5AB1) inhibits the activity of the F1 domain of ATP synthase and recognizes the catalytic β-subunit of ATP synthase. We located the antibody recognition site of MAb3D5AB1 in domains containing the active site of the β-subunit. MAb3D5AB1 also binds to purified Escherichia coli F1 with an affinity 25-fold higher than the affinity of angiostatin for this protein. MAb3D5AB1 inhibits the hydrolytic activity of F1 ATP synthase at lower concentrations than angiostatin. Like angiostatin, MAb3D5AB1 inhibits ATP generation by ATP synthase on the endothelial cell surface in acidic conditions, the typical tumor microenvironment where cell surface ATP synthase exhibits greater activity. MAb3D5AB1 disrupts tube formation and decreases intracellular pH in endothelial cells exposed to low extracellular pH. Neither angiostatin nor MAb3D5AB1 showed an antiangiogenic effect in the corneal neovascularization assay; however, both were effective in the low-pH environment of the chicken chorioallantoic membrane assay. Thus, MAb3D5AB1 shows angiostatin-like properties superior to angiostatin and may be exploited in cancer chemotherapy. [Cancer Res 2007;67(10):4716–24]
- 15 May 2007
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 67 (10) , 4716-4724
Angiostatin-Like Activity of a Monoclonal Antibody to the Catalytic Subunit of F1F0 ATP Synthase
The antiangiogenic protein angiostatin inhibits ATP synthase on the endothelial cell surface, blocking cellular proliferation. To examine the specificity of this interaction, we generated monoclonal antibodies (mAb) directed against ATP synthase. mAb directed against the β-catalytic subunit of ATP synthase (MAb3D5AB1) inhibits the activity of the F1 domain of ATP synthase and recognizes the catalytic β-subunit of ATP synthase. We located the antibody recognition site of MAb3D5AB1 in domains containing the active site of the β-subunit. MAb3D5AB1 also binds to purified Escherichia coli F1 with an affinity 25-fold higher than the affinity of angiostatin for this protein. MAb3D5AB1 inhibits the hydrolytic activity of F1 ATP synthase at lower concentrations than angiostatin. Like angiostatin, MAb3D5AB1 inhibits ATP generation by ATP synthase on the endothelial cell surface in acidic conditions, the typical tumor microenvironment where cell surface ATP synthase exhibits greater activity. MAb3D5AB1 disrupts tube formation and decreases intracellular pH in endothelial cells exposed to low extracellular pH. Neither angiostatin nor MAb3D5AB1 showed an antiangiogenic effect in the corneal neovascularization assay; however, both were effective in the low-pH environment of the chicken chorioallantoic membrane assay. Thus, MAb3D5AB1 shows angiostatin-like properties superior to angiostatin and may be exploited in cancer chemotherapy. [Cancer Res 2007;67(10):4716–24]
- 1 June 2002
- Published by Cold Spring Harbor Laboratory in RNA
- Vol. 8 (6) , 762-771
Autoimmune epitopes in messenger RNA
Patients with systemic autoimmune disorders produce autoantibodies against sequence-specific conformational RNA epitopes on U1 snRNA, 28S rRNA, and transfer RNAs. The molecular basis for immunological reactivity with these highly abundant and stable RNAs is not understood. Here, we report the existence of discrete RNA epitopes in messenger RNAs that are generally less abundant and less stable than snRNAs and tRNAs. An iterative selection and amplification procedure using pooled autoimmune patient sera identified immunoreactive mRNA species. Following deconvolution of the pools to identify the reactive sera, several mRNAs recognized by these autoantibodies were cloned and sequenced. Detailed analysis using one particular serum indicated reactivity against the messages encoding alternative splicing factor (ASF/SF2) and calmodulin. Deletion and site-directed mutagenesis determined that an epitope recognized by this serum is located in a 17-base stem-loop structure common to both messages. This serum was then used to immunoprecipitate native mRNAs encoding ASF/SF2 and calmodulin from total HeLa cell RNA. Our results demonstrate that despite its low abundance and instability, messenger RNA is capable of reacting with autoantibodies generated during an autoimmune response. These data are consistent with direct presentation as a model to explain the generation of RNA conformation-specific autoantibodies.
- 1 June 2002
- Published by Cold Spring Harbor Laboratory in RNA
- Vol. 8 (6) , 762-771
Autoimmune epitopes in messenger RNA
Patients with systemic autoimmune disorders produce autoantibodies against sequence-specific conformational RNA epitopes on U1 snRNA, 28S rRNA, and transfer RNAs. The molecular basis for immunological reactivity with these highly abundant and stable RNAs is not understood. Here, we report the existence of discrete RNA epitopes in messenger RNAs that are generally less abundant and less stable than snRNAs and tRNAs. An iterative selection and amplification procedure using pooled autoimmune patient sera identified immunoreactive mRNA species. Following deconvolution of the pools to identify the reactive sera, several mRNAs recognized by these autoantibodies were cloned and sequenced. Detailed analysis using one particular serum indicated reactivity against the messages encoding alternative splicing factor (ASF/SF2) and calmodulin. Deletion and site-directed mutagenesis determined that an epitope recognized by this serum is located in a 17-base stem-loop structure common to both messages. This serum was then used to immunoprecipitate native mRNAs encoding ASF/SF2 and calmodulin from total HeLa cell RNA. Our results demonstrate that despite its low abundance and instability, messenger RNA is capable of reacting with autoantibodies generated during an autoimmune response. These data are consistent with direct presentation as a model to explain the generation of RNA conformation-specific autoantibodies.
- Open Access
- 1 July 1996
- Published by Cold Spring Harbor Laboratory in Genome Research
- Vol. 6 (7) , 612-619
Bacterial artificial chromosome cloning and mapping of a 630-kb human extrachromosomal structure.
We have cloned and mapped a circular 630-kb human extrachromosomal structure (termed amplisome) using the bacterial artificial chromosome (BAC) cloning system. Twenty-one BACs were isolated from an amplisome-enriched library by colony hybridization. The insert sizes range from 25 to 143 kb, with an average size of 82 kb. The coverage of the amplisome in clones is approximately 2.7-fold. To construct a physical map of the amplisome, we used three different but complementary methods: hybridization, STS content mapping, and fingerprinting. In addition, we compared the advantages and the drawbacks of these techniques in mapping the amplisomal BACs. The 21 BACs were grouped into two contigs and the two small gaps (3.5 and 26.5 kb) were filled by screening of a human genomic BAC library. The organization of the amplisome revealed by the BAC-based physical map is consistent with the long-range restriction map reported previously. Our results demonstrate that a 630-kb region can be rapidly cloned and mapped into contigs by use of the BAC system. Because of the low frequency (<0.1%) of chimerism and rearrangement, these BAC clones are ready for DNA sequencing and functional analysis.
- 1 July 1996
- Published by Cold Spring Harbor Laboratory in Genome Research
- Vol. 6 (7) , 612-619
Open AccessBacterial artificial chromosome cloning and mapping of a 630-kb human extrachromosomal structure.
We have cloned and mapped a circular 630-kb human extrachromosomal structure (termed amplisome) using the bacterial artificial chromosome (BAC) cloning system. Twenty-one BACs were isolated from an amplisome-enriched library by colony hybridization. The insert sizes range from 25 to 143 kb, with an average size of 82 kb. The coverage of the amplisome in clones is approximately 2.7-fold. To construct a physical map of the amplisome, we used three different but complementary methods: hybridization, STS content mapping, and fingerprinting. In addition, we compared the advantages and the drawbacks of these techniques in mapping the amplisomal BACs. The 21 BACs were grouped into two contigs and the two small gaps (3.5 and 26.5 kb) were filled by screening of a human genomic BAC library. The organization of the amplisome revealed by the BAC-based physical map is consistent with the long-range restriction map reported previously. Our results demonstrate that a 630-kb region can be rapidly cloned and mapped into contigs by use of the BAC system. Because of the low frequency (<0.1%) of chimerism and rearrangement, these BAC clones are ready for DNA sequencing and functional analysis.
- 1 January 1989
- Published by Taylor & Francis in Connective Tissue Research
- Vol. 20 (1-4) , 23-32
Transforming Growth Factor Beta Mediates the Estrogen Induced Inhibition of Umr106 Cell Growth
A mitogenic response to transforming growth factor beta (TGF) occurred in the UMR106 cells cultured in serum-free medium and exposed serially to estradiol and TGF. This mitogenic response was lost when insulin was removed from the medium. TGF inhibited growth and increased the alkaline phosphatase content in the UMR106 cells cultured in medium lacking insulin. Prior exposure of the cells to estradiol enhanced this response. Monoclonal antibodies against TGF blocked the estradiol induced inhibition of growth after a two day incubation in medium devoid of insulin.
- 1 January 1989
- Published by Taylor & Francis in Connective Tissue Research
- Vol. 20 (1-4) , 23-32
Transforming Growth Factor Beta Mediates the Estrogen Induced Inhibition of Umr106 Cell Growth
A mitogenic response to transforming growth factor beta (TGF) occurred in the UMR106 cells cultured in serum-free medium and exposed serially to estradiol and TGF. This mitogenic response was lost when insulin was removed from the medium. TGF inhibited growth and increased the alkaline phosphatase content in the UMR106 cells cultured in medium lacking insulin. Prior exposure of the cells to estradiol enhanced this response. Monoclonal antibodies against TGF blocked the estradiol induced inhibition of growth after a two day incubation in medium devoid of insulin.